NANNETTI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 1.647
EU - Europa 192
AS - Asia 59
SA - Sud America 2
AF - Africa 1
Totale 1.901
Nazione #
US - Stati Uniti d'America 1.645
IT - Italia 67
CN - Cina 47
FI - Finlandia 30
DE - Germania 23
SE - Svezia 22
GB - Regno Unito 11
BE - Belgio 8
FR - Francia 8
IE - Irlanda 7
VN - Vietnam 6
UA - Ucraina 5
KR - Corea 3
CA - Canada 2
LU - Lussemburgo 2
AT - Austria 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
IL - Israele 1
IN - India 1
LI - Liechtenstein 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NL - Olanda 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.901
Città #
Fairfield 320
Woodbridge 155
Ann Arbor 151
Houston 150
Chandler 140
Ashburn 122
Seattle 119
Cambridge 113
Wilmington 101
San Diego 29
Helsinki 21
Boardman 18
Medford 18
Padova 18
Princeton 18
Des Moines 16
Roxbury 13
Columbus 12
Nanjing 9
Brussels 8
Dearborn 8
Dublin 7
Dong Ket 5
Kharkiv 5
Beijing 4
Vicenza 4
Florence 3
Hebei 3
Hefei 3
Kunming 3
Nanchang 3
Nürnberg 3
Shenyang 3
Turin 3
Edinburgh 2
London 2
Luxembourg 2
Mantova 2
Taiyuan 2
Zhengzhou 2
Abano Terme 1
Aprilia 1
Berlin 1
Borås 1
Boston 1
Bucharest 1
Changsha 1
Chengdu 1
Chiswick 1
Cochabamba 1
Copenhagen 1
Desio 1
Figline Valdarno 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Islington 1
Jiaxing 1
Jinan 1
Langfang 1
Las Vegas 1
Luoyang 1
Madrid 1
Manchester 1
Miami 1
Miami Beach 1
Munich 1
New Bedfont 1
Perugia 1
Pontypridd 1
Portland 1
Quzhou 1
Rabat 1
Reggio Calabria 1
Rockville 1
Salerno 1
San Francisco 1
Santa Clara 1
Santiago 1
Schaan 1
Siena 1
St Petersburg 1
Taizhou 1
Tappahannock 1
Tel Aviv 1
Temecula 1
Toronto 1
Trapani 1
Varese 1
Verona 1
Vienna 1
Warsaw 1
Washington 1
Wuhan 1
Totale 1.675
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 177
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 139
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 139
Antiviral strategies against influenza virus: towards new therapeutic approaches. 138
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 131
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 121
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 120
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 119
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 117
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 111
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 106
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 102
A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma 99
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 91
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 74
Corrigendum to “Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity” [Eur. J. Med. Chem. 138 (2017) 128–139] (S0223523417304610) (10.1016/j.ejmech.2017.06.015)) 64
Sviluppo e caratterizzazione di nuovi inibitori diretti contro la polimerasi dei virus dell'influenza di tipo A e B 57
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 51
Totale 1.956
Categoria #
all - tutte 4.682
article - articoli 4.462
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019167 0 0 6 1 1 3 4 0 1 30 65 56
2019/2020557 41 15 13 70 71 46 72 65 81 35 37 11
2020/2021292 25 18 12 17 7 15 11 25 50 10 56 46
2021/2022332 8 58 28 29 41 21 18 34 9 11 16 59
2022/2023333 47 41 5 38 63 31 4 33 32 5 27 7
2023/202467 5 34 28 0 0 0 0 0 0 0 0 0
Totale 1.956